Tumor Lysis Syndrome Induced by Hormonal Therapy in Metastatic Prostate Cancer: A Case Report

Marta Machado; Margarida Mourato; Catarina Negrão; Carolina Rodrigues; João Tiago Serra

doi:10.7759/cureus.98643

journal article Dec 07, 2025

Tumor Lysis Syndrome Induced by Hormonal Therapy in Metastatic Prostate Cancer: A Case Report

Marta Machado Margarida Mourato Catarina Negrão Carolina Rodrigues

João Tiago Serra

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.98643

Topics

No keywords indexed for this article. Browse by subject →

References

10

[1]

Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004, 127:3-11. 10.1111/j.1365-2141.2004.05094.x 10.1111/j.1365-2141.2004.05094.x

[2]

Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011, 364:1844-54. 10.1056/NEJMra0904569 10.1056/nejmra0904569

[3]

Cairo MS, Coiffier B, Reiter A, Younes A. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol. 2010, 149:578-86. 10.1111/j.1365-2141.2010.08143.x 10.1111/j.1365-2141.2010.08143.x

[4]

Alqurashi RM, Tamim HH, Alsubhi ZD, Alzahrani AA, Tashkandi E. Tumor lysis syndrome in patients with solid tumors: a systematic review of reported cases. Cureus. 2022, 14:e30652. 10.7759/cureus.30652 10.7759/cureus.30652

[5]

Tanvetyanon T, Choudhury AM. Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade. J Urol. 2004, 171:1627. 10.1097/01.ju.0000115884.21275.f4 10.1097/01.ju.0000115884.21275.f4

[6]

Lin CJ, Hsieh RK, Lim KH, Chen HH, Cheng YC, Wu CJ. Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer. South Med J. 2007, 100:916-7. 10.1097/SMJ.0b013e318137a665 10.1097/smj.0b013e318137a665

[7]

Mazzoni S. Tumor lysis syndrome in anti-androgen-treated metastatic prostate cancer. Int Urol Nephrol. 2016, 48:1837-8. 10.1007/s11255-016-1369-x 10.1007/s11255-016-1369-x

[8]

Mirrakhimov AE, Ali AM, Khan M, Barbaryan A. Tumor lysis syndrome in solid tumors: an up to date review of the literature. Rare Tumors. 2014, 6:5389. 10.4081/rt.2014.5389 10.4081/rt.2014.5389

[9]

Fontana F, Marzagalli M, Montagnani Marelli M, Raimondi M, Moretti RM, Limonta P. Gonadotropin-releasing hormone receptors in prostate cancer: molecular aspects and biological functions. Int J Mol Sci. 2020, 21:9511. 10.3390/ijms21249511 10.3390/ijms21249511

[10]

Shore ND. Experience with degarelix in the treatment of prostate cancer. Ther Adv Urol. 2013, 5:11-24. 10.1177/1756287212461048 10.1177/1756287212461048

Metrics

0

Citations

10

References

Details

Published: Dec 07, 2025

Authors

Cite This Article

Marta Machado, Margarida Mourato, Catarina Negrão, et al. (2025). Tumor Lysis Syndrome Induced by Hormonal Therapy in Metastatic Prostate Cancer: A Case Report. Cureus. https://doi.org/10.7759/cureus.98643

Tumor Lysis Syndrome Induced by Hormonal Therapy in Metastatic Prostate Cancer: A Case Report

You May Also Like